Table 3.
Unadjusted and Adjusted Cox Regression Analysis for the Association Between Baseline MR >2+ and the Study Outcomes
| Unadjusted | |||
|---|---|---|---|
| HR | 95% CI | P value | |
| Primary outcome | 4.15 | 2.42–7.12 | <0.001 |
| All‐cause death | 5.13 | 2.38–11.06 | <0.001 |
| HF rehospitalization | 4.93 | 2.46–9.88 | <0.001 |
| Cardiac death | 9.09 | 3.32–24.89 | <0.001 |
| Noncardiac death | 1.43 | 0.34–5.98 | 0.624 |
| Adjusted* | |||
|---|---|---|---|
| aHR | 95% CI | P value | |
| Primary outcome | 3.29 | 1.86–5.83 | <0.001 |
| All‐cause death | 4.68 | 2.02–10.85 | <0.001 |
| HF rehospitalization | 3.99 | 1.93–8.23 | <0.001 |
| Cardiac death | 10.45 | 3.64–29.96 | <0.001 |
| Noncardiac death | 0.78 | 0.17–3.45 | 0.738 |
aHR indicates adjusted hazard ratio; HF, heart failure; and HR, hazard ratio.
*
List of variables entered in the propensity score weighting model: age, EuroSCORE II, NYHA class, paradoxical/classical form, baseline LVEF, RV dysfunction, implantation of self‐expandable/balloon‐expandable prosthesis, and predischarge LVEF.